Frazier Life Sciences Management’s AN2 Therapeutics ANTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,088,889	Closed	-$4.49M	–	54
2024 Q2	$4.49M	Buy	2,088,889 +700,000	+50%	+$1.51M	0.21%	44
2024 Q1	$4.51M	Hold	1,388,889	–	–	0.19%	46
2023 Q4	$28.5M	Hold	1,388,889	–	–	1.52%	18
2023 Q3	$22.3M	Buy	+1,388,889	New	+$22.3M	1.48%	19